Advertisement

Ads Placeholder
Loading...

Alvotech

ALVONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.65
$0.03(0.83%)
U.S. Market opens in 0h 56m

Alvotech (ALVO) Stock Overview

Explore Alvotech’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio36.50
EPS (TTM)$0.10
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$2.09
3 Months$0.00
1 Year Target$0.44

ALVO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alvotech (ALVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.44.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.50 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.83%
5-Day Change
13.003%
1-Month Change
-3.95%
3-Month Change
-27.00%
6-Month Change
-56.13%
Year-to-Date (YTD) Change
-27.00%
1-Year Change
-60.63%
3-Year Change
-72.05%
5-Year Change
-67.38%
All-Time (Max) Change
-67.38%

Contact Information

354 422 4500
Saemundargata 15-19, Luxembourg, NaN, 102

Company Facts

10,120 Employees
IPO DateJun 16, 2022
CountryIS
Actively Trading

Frequently Asked Questions